logo
episode-header-image
Mar 2025
23m 43s

Continuous Ranibizumab via Port Delivery...

JAMA NETWORK
About this episode

Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD.

Related Content:

Up next
Sep 18
Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players
Interview with Nicholas G. Murray, PhD, author of Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players. Hosted by Neil Bressler, MD. Related Content: Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football P ... Show More
17m 32s
Aug 7
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD. Related Content: Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention o ... Show More
17m 32s
Jul 24
Steroids and Cross-Linking for Ulcer Treatment
Interview with Jennifer R. Rose-Nussbaumer, MD, author of Steroids and Cross-Linking for Ulcer Treatment: The SCUT II Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Steroids and Cross-Linking for Ulcer Treatment 
15m 20s
Recommended Episodes
Feb 2025
LifeBTK Trial: Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
In this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resorbable scaffold for the below-knee popliteal space. Guest: Dr. DeRubertis, is the ... Show More
47m 12s
Aug 14
Common Medications and Diabetic Macular Edema
Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ... Show More
18m 26s
Dec 2024
EM Quick Hits 61 TEE in Cardiac Arrest, Nebulized Ketamine, Cellulitis Update, SQ Insulin for DKA, Medicolegal DDx Documentation Tips
On this month's EM Quick Hits podcast: Ross Prager on TEE in cardiac arrest, Justin Morgenstern on nebulized ketamine for analgesia in the ED, Hans Rosenberg & Krishin Yadav on standardizing cellulitis management, Mathew McArther on latest studies on subcutaneous insulin protocol ... Show More
59m 53s
Apr 2025
#481 Prediabetes and Diabetes Prevention with Dr. Scott Isaacs
Conquer prediabetes and diabetes prevention! We’re joined by Dr. Scott Isaacs, who provides essential pearls on navigating screening tests for diabetes and prediabetes, identifying atypical cases of prediabetes, and individualizing management of prediabetes with lifestyle changes ... Show More
1h 33m
Jun 2025
PRAGUE-25 Trial: Catheter Ablation Versus Antiarrhythmic Drugs With Risk Factor Modification for Treatment of AF
The PRAGUE-25 study evaluated the effectiveness of two treatment strategies in patients with both atrial fibrillation (AF) and obesity: catheter ablation versus lifestyle modification (including weight loss and increased physical activity) combined with antiarrhythmic drug therap ... Show More
12m 59s
Mar 2025
#474 Resistant Hypertension the Next Frontier
Treat Hypertension Like No Doctor Has Ever Treated Hypertension Before Treating hypertension never gets boring. Learn about emerging therapies and how to continue to tackle this common diagnosis like a pro.  Dr. Jordy Cohen (@jordybc.bsky.social) leads us through her approach to ... Show More
1h 17m
Jan 2025
Relationship Between Intermittent Hypoxia, COPD and Comorbidities
Dr. Amy Attaway and Dr. Dan Culver review the emerging relationship between COPD patients who have intermittent hypoxemia and an increase they have in co-morbidities and mortality. They discuss how multiple associative studies suggest that intermittent hypoxemia may impact muscul ... Show More
21m 50s
Aug 18
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed. 
29m 55s
Jun 2024
Episode 906: Case Study of Hypernatremia
Contributor: Aaron Lessen MD Educational Pearls: The case: A gentleman came in from a nursing home with symptoms concerning for sepsis. He was hypotensive, hypoxic, febrile, and mentally altered. His past medical history included previous strokes which had left him with deficits ... Show More
3m 46s
May 2012
IDSA Guideline Update - Diabetic Foot Infections
The Infectious Diseases Society of America's Guideline Update presents concise summaries of important IDSA guidelines. In this episode, Dr. Benjamen Lipsky joins us to discuss the 2012 IDSA Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectio ... Show More
22m 19s